buthionine sulfoximine has been researched along with Pancreatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Han, H; Ji, J; Jin, Q; Wang, Y | 1 |
| Filipski, E; Lévi, F; Li, XM | 1 |
| Ator, MA; Bollt, O; Dorsey, BD; Kuwada, SK; Lao, X; Li, X; Lisko, JG; Ruggeri, BA; Scaife, CL; Shea, JE; Shen, Y; Theroff, JP; Zificsak, CA | 1 |
3 other study(ies) available for buthionine sulfoximine and Pancreatic Neoplasms
| Article | Year |
|---|---|
The rational design of a gemcitabine prodrug with AIE-based intracellular light-up characteristics for selective suppression of pancreatic cancer cells.
Topics: Amino Acid Sequence; Antineoplastic Agents; Buthionine Sulfoximine; Cathepsin B; Cell Line, Tumor; Cysteine Proteinase Inhibitors; Deoxycytidine; Dipeptides; Endocytosis; Fluorescent Dyes; Gemcitabine; Glutathione; Humans; Integrin alphaVbeta3; Oxidation-Reduction; Pancreatic Neoplasms; Prodrugs | 2015 |
Pharmacological modulation of cisplatin toxicity rhythms with buthionine sulfoximine in mice bearing pancreatic adenocarcinoma (PO3).
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Buthionine Sulfoximine; Circadian Rhythm; Cisplatin; Drug Tolerance; Female; Glutathione; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Pancreatic Neoplasms; Sulfhydryl Compounds; Weight Loss | 1998 |
Design, synthesis, and biological evaluation of sulfonyl acrylonitriles as novel inhibitors of cancer metastasis and spread.
Topics: Acrylonitrile; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Female; HT29 Cells; Humans; Mice; Molecular Structure; Ovarian Neoplasms; Pancreatic Neoplasms; Structure-Activity Relationship; Sulfones | 2015 |